The Intercycle Variability in Patients Treated With Repeated Cycles of Gonadotropins is Due to Intrinsic Factors and is Not Eliminated by Recombinant Gonadotropins
Assessment of Pelvic Adhesions: Statistical Validation, Reliability and Interobserver Correlation Using a Modification of the More Comprehensive Adhesion Scoring Method (MCASM)
Patient Tolerance to Recombinant Human Follicle Stimulating Hormone (r-hFSH, Gonal-F®) and Leuprolide Acetate (LA, Lupron®) Administered in Single or Separate Injections in Women Undergoing IVF
Weight Correlates with Gonadotropin Requirements and Patient Response
Impact of Price Variability on Cost-Effectiveness Modeling of rFSH Vs. uFSH in ART in the United States
Poor Response to Ovarian Hyperstimulation Predicts Spontaneous Ovulation
DHEA supplementation augments exercise performance in postmenopausal women
Recombinant FSH Provides More Efficient, Cost-Effective Stimulation for Ovulation Induction/Intrauterine Insemination (OI/IUI) Cycles Than Highly Purified Urinary FSH
The effect of prolonged GnRH agonist therapy on in vitro fertilization-embryo transfer cycle outcome in endometriosis patients a multicenter randomized trial
Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)
DHEA supplementation augments exercise performance in postmenopausal women
High order multiples and gonadotropin/IUI cycles: how can we reduce the risks?
- Previous Posts
- 1
- 2
- 3
- 4
- 5
- Next Posts